DSE: SQURPHARMA Statistics

Total Valuation

Square Pharmaceuticals PLC. has a market cap or net worth of BDT 197.50 billion. The enterprise value is 133.42 billion.

Market Cap	197.50B
Enterprise Value	133.42B

Important Dates

The last earnings date was Thursday, November 28, 2024.

Earnings Date	Nov 28, 2024
Ex-Dividend Date	Nov 24, 2024

Share Statistics

Square Pharmaceuticals PLC. has 886.45 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	886.45M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	35.97%
Owned by Institutions (%)	4.39%
Float	567.55M

Valuation Ratios

The trailing PE ratio is 9.40 and the forward PE ratio is 8.27.

PE Ratio	9.40
Forward PE	8.27
PS Ratio	2.82
PB Ratio	1.49
P/TBV Ratio	1.49
P/FCF Ratio	24.37
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.95, with an EV/FCF ratio of 16.46.

EV / Earnings	6.35
EV / Sales	1.90
EV / EBITDA	5.95
EV / EBIT	6.63
EV / FCF	16.46

Financial Position

The company has a current ratio of 11.41, with a Debt / Equity ratio of 0.01.

Current Ratio	11.41
Quick Ratio	8.96
Debt / Equity	0.01
Debt / EBITDA	0.07
Debt / FCF	0.17
Interest Coverage	63.87

Financial Efficiency

Return on equity (ROE) is 16.55% and return on invested capital (ROIC) is 8.42%.

Return on Equity (ROE)	16.55%
Return on Assets (ROA)	8.05%
Return on Capital (ROIC)	8.42%
Revenue Per Employee	5.62M
Profits Per Employee	1.69M
Employee Count	12,453
Asset Turnover	0.52
Inventory Turnover	3.01

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.20% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+6.20%
50-Day Moving Average	219.02
200-Day Moving Average	217.74
Relative Strength Index (RSI)	59.80
Average Volume (20 Days)	379,026

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Square Pharmaceuticals PLC. had revenue of BDT 70.04 billion and earned 21.02 billion in profits. Earnings per share was 23.71.

Revenue	70.04B
Gross Profit	31.88B
Operating Income	17.33B
Pretax Income	25.12B
Net Income	21.02B
EBITDA	19.61B
EBIT	17.33B
Earnings Per Share (EPS)	23.71

Full Income Statement

Balance Sheet

The company has 55.29 billion in cash and 1.36 billion in debt, giving a net cash position of 64.09 billion or 72.30 per share.

Cash & Cash Equivalents	55.29B
Total Debt	1.36B
Net Cash	64.09B
Net Cash Per Share	72.30
Equity (Book Value)	132.76B
Book Value Per Share	149.76
Working Capital	70.39B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 13.52 billion and capital expenditures -5.41 billion, giving a free cash flow of 8.10 billion.

Operating Cash Flow	13.52B
Capital Expenditures	-5.41B
Free Cash Flow	8.10B
FCF Per Share	9.14

Full Cash Flow Statement

Margins

Gross margin is 45.52%, with operating and profit margins of 24.75% and 30.01%.

Gross Margin	45.52%
Operating Margin	24.75%
Pretax Margin	35.87%
Profit Margin	30.01%
EBITDA Margin	28.00%
EBIT Margin	24.75%
FCF Margin	11.57%

Dividends & Yields

This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 4.94%.

Dividend Per Share	11.00
Dividend Yield	4.94%
Dividend Growth (YoY)	4.76%
Years of Dividend Growth	6
Payout Ratio	43.93%
Buyback Yield	n/a
Shareholder Yield	4.94%
Earnings Yield	10.64%
FCF Yield	4.10%

Dividend Details

Stock Splits

The last stock split was on November 23, 2020. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 23, 2020
Split Type	Forward
Split Ratio	1.05

Scores

Square Pharmaceuticals PLC. has an Altman Z-Score of 16.76.

Altman Z-Score	16.76
Piotroski F-Score	n/a